Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
収録刊行物
-
- PLoS Medicine
-
PLoS Medicine 2 e73-, 2005
- Tweet
詳細情報
-
- CRID
- 1571698600294059648
-
- NII論文ID
- 10018676662
-
- データソース種別
-
- CiNii Articles